Inventiva SA (IVA)
3.78
+0.03
(+0.80%)
USD |
NASDAQ |
Sep 18, 16:00
3.765
-0.02
(-0.40%)
After-Hours: 20:00
Inventiva Enterprise Value : 679.05M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 679.05M |
| September 17, 2026 | 673.25M |
| September 16, 2026 | 680.98M |
| September 15, 2026 | 694.51M |
| September 14, 2026 | 698.37M |
| September 11, 2026 | 725.42M |
| September 10, 2026 | 748.61M |
| September 09, 2026 | 808.52M |
| September 08, 2026 | 851.03M |
| September 04, 2026 | 872.28M |
| September 03, 2026 | 883.88M |
| September 02, 2026 | 887.74M |
| September 01, 2026 | 870.35M |
| August 31, 2026 | 852.96M |
| August 28, 2026 | 857.79M |
| August 27, 2026 | 895.47M |
| August 26, 2026 | 880.01M |
| August 25, 2026 | 854.89M |
| August 24, 2026 | 856.82M |
| August 21, 2026 | 852.96M |
| August 20, 2026 | 847.16M |
| August 19, 2026 | 868.42M |
| August 18, 2026 | 845.23M |
| August 17, 2026 | 856.82M |
| August 14, 2026 | 837.50M |
| Date | Value |
|---|---|
| August 13, 2026 | 837.50M |
| August 12, 2026 | 852.96M |
| August 11, 2026 | 860.69M |
| August 10, 2026 | 866.49M |
| August 07, 2026 | 876.15M |
| August 06, 2026 | 849.09M |
| August 05, 2026 | 860.69M |
| August 04, 2026 | 820.11M |
| August 03, 2026 | 769.87M |
| July 31, 2026 | 814.31M |
| July 30, 2026 | 841.37M |
| July 29, 2026 | 820.11M |
| July 28, 2026 | 845.23M |
| July 27, 2026 | 837.50M |
| July 24, 2026 | 810.45M |
| July 23, 2026 | 820.11M |
| July 22, 2026 | 825.91M |
| July 21, 2026 | 814.31M |
| July 20, 2026 | 801.75M |
| July 17, 2026 | 841.37M |
| July 16, 2026 | 822.04M |
| July 15, 2026 | 812.38M |
| July 14, 2026 | 798.85M |
| July 13, 2026 | 779.53M |
| July 10, 2026 | 779.53M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | 518.01M |
| Cellectis SA | 91.50M |
| Genfit SA | -- |
| Innate Pharma SA | -- |
Enterprise Value Related Metrics
| Earnings Yield | -75.15% |
| Normalized Earnings Yield | -45.98 |